Validating liver imaging in children
Part of Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests if non-invasive imaging (like ultrasound) can replace liver biopsies in children with liver disease. It may help avoid the need for a needle biopsy in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child are 0 to 18 years old.
- You or your child have a suspected or confirmed liver disease and are already scheduled for a liver biopsy at Queen Silvia Children's Hospital.
- Or, you or your child are scheduled for a kidney biopsy and can serve as a healthy comparison group.
- You and your child understand the study and agree to take part (signed consent).
- There are no technical issues that would make the imaging measurements impossible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of liver scanners that measure liver stiffness (a sign of scarring) to see if a new handheld device works as well as the standard one. If the devices are similar, it may allow easier and more affordable liver monitoring for people with chronic liver disease.
This study uses MRI scans to look at the livers of children with obesity, to find early signs of liver problems. It may help doctors understand how to protect the liver in children.
This study uses a special ultrasound technique to measure how much scarring (fibrosis) has built up in the liver of children with cholestatic liver disease. The goal is to see if this non-invasive method can assess the degree of liver damage without needing a biopsy.
This study explores if a new ultrasound technique can detect fatty liver disease in children. It aims to find a simpler, safer way to check liver health without needing an MRI or biopsy.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study looks back at liver biopsy results from children under 18 to understand what types of liver diseases are common and how biopsies help diagnose them. It may help improve care for children with liver problems.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.